Ciprofloxacin Activity in Cyst Fluid from Polycystic Kidneys

Overview

Journal Antimicrob Agents Chemother

Publisher American Society for Microbiology

Specialty Pharmacology

Date 1988 Jun 1

PMID 3415205

Citations 10

Authors

L W Elzinga

T A Golper

A L Rashad

M E Carr

W M Bennett

Affiliations

Soon will be listed here.

Abstract

Renal cyst infection in patients with polycystic kidney disease (PKD) is often unresponsive to standard antimicrobial therapy, in part because of the failure of most antibiotics to adequately penetrate cyst fluid. Ciprofloxacin, a new quinolone antibiotic, possesses in vitro activity against most pathogens likely to be encountered in renal cyst infection. To study the potential usefulness of ciprofloxacin for the treatment of cyst infection, fluid from 70 cysts was obtained from seven patients with polycystic kidney disease who were receiving the drug. Cysts were categorized as nongradient or gradient by the sodium concentration in the fluid. The ciprofloxacin concentration within cysts was measured, and the cyst fluid bactericidal activity against likely cyst fluid pathogens was determined. The mean (+/- standard error) ciprofloxacin concentration was 12.7 +/- 2.9 micrograms/ml. Preferential accumulation of ciprofloxacin occurred in gradient cysts; these levels exceeded levels in serum by more than fourfold. Cyst fluid bactericidal activity titers were uniformly high against Escherichia coli and Proteus mirabilis, while less activity was observed against Streptococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis.

Citing Articles

Cyst infection in autosomal dominant polycystic kidney disease: our experience at Toranomon Hospital and future issues.

Suwabe T Clin Exp Nephrol. 2020; 24(9):748-761.

PMID: 32700112 PMC: 7474715. DOI: 10.1007/s10157-020-01928-2.

Multiple urinary tract infections are associated with genotype and phenotype in adult polycystic kidney disease.

Eroglu E, Kocyigit I, Cetin M, Zararsiz G, Imamoglu H, Bayramov R Clin Exp Nephrol. 2019; 23(10):1188-1195.

PMID: 31165946 DOI: 10.1007/s10157-019-01752-3.

Bacteremic kidney cyst infection caused by Helicobacter cinaedi.

Ito K, Yamamoto T, Nishio H, Sawaya A, Murakami M, Kitagawa A CEN Case Rep. 2017; 5(2):121-124.

PMID: 28508961 PMC: 5413748. DOI: 10.1007/s13730-015-0207-9.

Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease.

Neuville M, Hustinx R, Jacques J, Krzesinski J, Jouret F PLoS One. 2016; 11(8):e0161277.

PMID: 27529555 PMC: 4987061. DOI: 10.1371/journal.pone.0161277.

Cyst infection in autosomal dominant polycystic kidney disease: causative microorganisms and susceptibility to lipid-soluble antibiotics.

Suwabe T, Araoka H, Ubara Y, Kikuchi K, Hazue R, Mise K Eur J Clin Microbiol Infect Dis. 2015; 34(7):1369-79.

PMID: 25851811 DOI: 10.1007/s10096-015-2361-6.

References

DALGAARD O . Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl. 1957; 328:1-255. View

Crump B, Wise R, Dent J . Pharmacokinetics and tissue penetration of ciprofloxacin. Antimicrob Agents Chemother. 1983; 24(5):784-6. PMC: 185942. DOI: 10.1128/AAC.24.5.784. View

Huseman R, Grady A, Welling D, Grantham J . Macropuncture study of polycystic disease in adult human kidneys. Kidney Int. 1980; 18(3):375-85. DOI: 10.1038/ki.1980.148. View

Bricker N, Patton J . Cystic disease of the kidneys; a study of dynamics and chemical composition of cyst fluid. Am J Med. 1955; 18(2):207-19. DOI: 10.1016/0002-9343(55)90236-9. View

Wise R, Andrews J, Edwards L . In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents. Antimicrob Agents Chemother. 1983; 23(4):559-64. PMC: 184701. DOI: 10.1128/AAC.23.4.559. View

Chin N, Neu H . Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother. 1984; 25(3):319-26. PMC: 185508. DOI: 10.1128/AAC.25.3.319. View

Daschner F, Westenfelder M, Dalhoff A . Penetration of ciprofloxacin into kidney, fat, muscle and skin tissue. Eur J Clin Microbiol. 1986; 5(2):212-3. DOI: 10.1007/BF02013992. View

Schwab S, Hinthorn D, DIEDERICH D, CUPPAGE F, Grantham J . PH-dependent accumulation of clindamycin in a polycystic kidney. Am J Kidney Dis. 1983; 3(1):63-6. DOI: 10.1016/s0272-6386(83)80012-2. View

Grantham J, Geiser J, Evan A . Cyst formation and growth in autosomal dominant polycystic kidney disease. Kidney Int. 1987; 31(5):1145-52. DOI: 10.1038/ki.1987.121. View

10.

Jacobsson L, Lindqvist B, Michaelson G, Bjerle P . Fluid turnover in renal cysts. Acta Med Scand. 1977; 202(4):327-9. DOI: 10.1111/j.0954-6820.1977.tb16837.x. View

11.

Wolfson J, Hooper D . The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother. 1985; 28(4):581-6. PMC: 180310. DOI: 10.1128/AAC.28.4.581. View

12.

Schwab S . Efficacy of chloramphenicol in refractory cyst infections in autosomal dominant polycystic kidney disease. Am J Kidney Dis. 1985; 5(5):258-61. DOI: 10.1016/s0272-6386(85)80118-9. View

13.

Elzinga L, Golper T, Rashad A, Carr M, Bennett W . Trimethoprim-sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int. 1987; 32(6):884-8. DOI: 10.1038/ki.1987.290. View

14.

De Bono D, Evans D . The management of polycystic kidney disease with special reference to dialysis and transplantation. Q J Med. 1977; 46(183):353-63. View

15.

Schwab S, Bander S, KLAHR S . Renal infection in autosomal dominant polycystic kidney disease. Am J Med. 1987; 82(4):714-8. DOI: 10.1016/0002-9343(87)90005-2. View

16.

Perrone R . In vitro function of cyst epithelium from human polycystic kidney. J Clin Invest. 1985; 76(4):1688-91. PMC: 424166. DOI: 10.1172/JCI112155. View

17.

Rothermel F, Miller Jr F, Sanford E, Drago J, Rohner T . Clinical and radiographic findings of focally infected polycystic kidneys. Urology. 1977; 9(5):580-5. DOI: 10.1016/0090-4295(77)90262-x. View

18.

Wickre C, Bennett W . Renal cyst epithelial transport in non-uremic polycystic kidney disease. Kidney Int. 1983; 23(3):514-8. DOI: 10.1038/ki.1983.49. View

19.

Waters W, HERSHMAN H, Klein L . Management of infected polycystic kidneys. J Urol. 1979; 122(3):383-5. DOI: 10.1016/s0022-5347(17)56421-6. View

20.

CUPPAGE F, Huseman R, Chapman A, Grantham J . Ultrastructure and function of cysts from human adult polycystic kidneys. Kidney Int. 1980; 17(3):372-81. DOI: 10.1038/ki.1980.43. View